Tirzepatide offers dual benefits by acting on both GLP-1 and GIP receptors for enhanced fat reduction
If you have a vial, wash your hands and wipe down the rubber stopper with an alcohol swab
Have a BMI that is 30 or 35 with one or more previously diagnosed conditions: Controlled Type II Diabetes, Sleep Apnea, High Cholesterol, High Triglycerides, Prediabetes, High Blood Pressure, Heart disease, Osteoarthritis, Polycystic Ovarian Syndrome (PCOS), Non-alcoholic Fatty Liver Disease (NAFLD), Cardiovascular Disease, Gastroesophageal Reflux Disease (GERD), Depression, Anxiety, Weight-Related Psychosocial Distress, Stroke, Coronary Artery Disease, Metabolic Syndrome, Insulin Resistance, Body Pain, Infertility, Hypothyroidism, Sexual Dysfunction
To understand why this combination exists, you need to understand what each component does on its own
Switching costs if drops prove ineffective and a transition to injectable tirzepatide becomes necessary